Toll-like receptors and cytokines in immune responses to persistent mycobacterial and Salmonella infections

International Journal of Medical Microbiology

Volumn 299, Issue 3, 2009, Pages 177-185

  Balaram, Prabha ^a   Kien, Phua Kia ^a   Ismail, Asma ^a  

^a INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

Author keywords

Bacterial persistence; Cytokines; Mycobacteria; Salmonella; TLRs

Indexed keywords

CYTOKINE; TOLL LIKE RECEPTOR;

BACTERIAL INFECTION; DISEASE SEVERITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PERSISTENT INFECTION; SALMONELLOSIS; SHORT SURVEY;

CARRIER STATE; CYTOKINES; HUMANS; MYCOBACTERIUM INFECTIONS; SALMONELLA INFECTIONS; TOLL-LIKE RECEPTORS;

EID: 60849109490     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2008.08.004     Document Type: Short Survey

References (67)

1. Abel B., Thieblemont N., Quesniaux V.J., Brown N., Mpagi J., Miyake K., et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169 (2002) 3155-3162
2. Akira S. Toll receptor families: structure and function. Semin. Immunol. 16 (2004) 1-2
3. Arai T., Hiromatsu K., Nishimura H., Kimura Y., Kobayashi N., Ishida H., Nimura Y., and Yoshikai Y. Endogenous interleukin 10 prevents apoptosis in macrophages during Salmonella infection. Biochem. Biophys. Res. Commun. 213 (1995) 600-607
4. Bafica A., Scanga C.A., Schito M.L., Hieny S., and Sher A. In vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2. J. Immunol. 171 (2003) 1123-1127
5. Bafica A., Scanga C.A., Feng C.G., Leifer C., Cheever A., and Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202 (2005) 1715-1724
6. Barton G.M., and Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14 (2002) 380-383
7. Bernheiden M., Heinrich J.M., Minigo J., Schutt C., Stelter F., Freeman M., Golenbock D., and Jack R.S. LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection. J. Endotox. Res. 7 (2001) 447-450
8. Bhat B.A., Dhar K.L., Puri S.C., Quirishi M.A., Khajuria A., Gupta A., and Quazi G.N. Isolation, characterization and biological evaluation of Datura lactones as potential immunomodulators. Biol. Org. Med. Chem. 13 (2005) 6672-6677
9. Bourreau E., Prévot G., Pradinaud R., and Launois P. Unresponsiveness of specific T cells to IL-12 is associated with active cutaneous leishmaniasis owing to Leishmania guyanensis. Scand. J. Immunol. 54 (2001) 335-339
10. Butler T., Ho M., Acharya G., Tiwari M., and Gallati H. Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrob. Agents Chemother. 37 (1993) 2418-2421
11. Caron J., Larivière L., Nacache M., Tam M., Stevenson M.M., McKerly C., Gros P., and Malo D. Influence of Slc11a1 on the outcome of Salmonella enterica serovar Enteritidis infection in mice is associated with Th polarization. Infect. Immun. 74 (2006) 2787-2802
12. Constant S.L., and Bottomly K. Induction of Th1 and Th2 CD4T cell responses: the alternative approaches. Annu. Rev. Immunol. 15 (1997) 297-322
13. Delobel P., Launois P., Djossou F., Sainte-Marie D., and Pradinaud R. American cutaneous leishmaniasis, lepromatous leprosy, and pulmonary tuberculosis coinfection with downregulation of the T-helper 1 cell response. Clin. Infect. Dis. 37 (2003) 628-633
14. Everhart J.E. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol. Clin. North Am. 29 (2000) 559-578
15. Fan J., and Malik A.B. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat. Med. 9 (2003) 315-321
16. Feng C.G., Jankovic D., Kullberg M., Cheever A., Scanga C.A., Hieny S., Caspar P., Yap G.S., and Sher A. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J. Immunol. 174 (2005) 4185-4192
17. Gehring A.J., Rojas R.E., Canaday D.H., Lakey D.L., Harding C.V., and Boom W.H. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon regulated HLA-DR and FcγR1 on human macrophages through Toll-like receptor 2. Infect. Immun. 71 (2003) 4487-4497
18. George S.K., Rajesh R., Sunil Kumar S., Sulekha B., and Balaram P. A polyherbal ayurvedic drug - Indukantha Ghritha as an adjuvant to cancer chemotherapy via immunomodulation. Immunobiology 213 (2008) 641-649 10.1016/j.imbio.2008.02.004
19. Gerold G., Zychlinsky A., and de Diego J.L. What is the role of Toll-like receptors in bacterial infections?. Sem. Immunol. 19 (2007) 41-47
20. Gooding T.M., Johnson P.D., Smith M., Kemp A.S., and Robins-Browne R.M. Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect. Immun. 70 (2002) 5562-5567
21. Hirschfeld M., Weis J.J., Toshchakov V., Salkowski C.A., Cody M.J., Ward D.C., Qureshi N., Michalek S.M., and Vogel S.N. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69 (2001) 1477-1482
22. Hue N.T., Lanh M.N., Phuong L.T., Vinh H., Chinh N.T., Hien T.T., Farrar J.J., and Dunstan S.J. Toll-like receptor 4 (TLR4) and typhoid fever in Vietnam. Proc. ASM Conference 'Salmonella: From Pathogenesis to Therapeutics'. Am. Soc. Microbiol. B 38 (2006) 56
23. Jancovic D., Liu Z., and Gause W.C. Th1- and Th2-cell commitment during infectious diseases: asymmetry in divergent pathways. Trends Immunol. 22 (2001) 450-457
24. Jarvis B.W., Harris T.H., Qureshi N., and Splitter G.A. Rough lipopolysaccharide from Brucella abortus and Escherichia coli differentially activates the same mitogen-activated protein kinase signaling pathways for tumor necrosis factor alpha in RAW 264.7 macrophage-like cells. Infect. Immun. 70 (2002) 7165-7168
25. Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 19 (2007) 39-45
26. Kamath A.B., Alt J., Debbabi H., and Behar S.M. Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis. Infect. Immun. 71 (2003) 4112-4118
27. Kang T.J., Seong-Beom S., and Gue-Tae C. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 20 (2002) 56-62
28. Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., Siegel J.N., and Braun M.M. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N. Engl. J. Med. 345 (2001) 1098-1104
29. Kristian S.A., Lauth X., Nizet V., Goetz F., Neumeister B., Peschel A., and Landmann R. Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J. Infect. Dis. 188 (2003) 414-423
30. Lazarevic V., Nolt D., and Flynn J.L. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune response. J. Immunol. 175 (2005) 1107-1117
31. Lienhardt C., Azzurri A., Amedei A., Fielding K., Sillah J., Sow O.Y., Bah B., Benagiano M., Diallo A., Manetti R., Manneh K., Gustafson P., Bennett S., D'Elios M.M., McAdam K., and Prete G.D. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur. J. Immunol. 32 (2002) 1605-1613
32. Lorenz E., Mira J., Frees K., and Schwartz D. Relevance of mutations in the TLR4 receptor in patients with Gram negative septic shock. Arch. Int. Med. 162 (2002) 1028-1032
33. Magalhaes J.G., Tattoli I., and Girardin S.E. The intestinal epithelial barrier: How to distinguish between the microbial flora and pathogens. Sem. Immunol. 19 (2007) 106-115
34. Manca C., Tsenova L., Begtold A., Freeman S., Tovey M., Musser J.M., Barry III C.E., Freedman V.H., and Kaplan G. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-γ. Proc. Natl. Acad. Sci. USA 98 (2001) 5752-5757
35. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
36. Mizuno Y., Takada H., Nomura A., Jin C.-H., Hattori H., Ihara K., Aoki T., Eguchi K., and Hara T. Th1 and Th1-inducing cytokines in salmonella infection. Clin. Exp. Immunol. 131 (2003) 111-117
37. Modlin R.L. Cytokine responses in leprosy lesions. Jpn. J. Lepr. 64 (1995) 85-88
38. Mohan V.P., Scanga C.A., Yu K., Scott H.M., Tanaka K.E., Tsang E., Chih Tsai M., Flynn J.L., and Chan J. Effects of tumour necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect. Immun. 69 (2001) 1847-1855
39. 1+/+ mice and can be reactivated by IFN-neutralization. J. Exp. Med. 199 (2004) 231-241
40. Monack D.M., Mueller A., and Falkow S. Persistent bacterial infections: the interface of the pathogen and the immune system. Nat. Rev. Microbiol. 2 (2004) 747-765
41. Mowat A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3 (2003) 331-341
42. Mueller T., Terada T., Rosenberg I.M., Shibolet O., and Podolsky K. Th2 cytokines down-regulate TLR expression and function in human epithelial cells. J. Immunol. 176 (2006) 5805-5814
43. Netea M.G., Sutmuller R., Hermann C., van der Graaf C.A.A., van der Meer J.W.M., van Krieken J.H., Hartung T., Adema G., and Kullberg B.J. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172 (2004) 3712-3718
44. Netea M.G., van der Meer J.W.M., Sutmuller R.P., Adema G.J., and .Kullberg B.J. From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob. Agents Chemother. 49 (2005) 3991-3996
45. Okwor I., and Uzonna J. Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies. Immunol. Res. (2008) 10.1007/s12026-008-8016-2
46. Otte J.M., Cario E., and Podolsky D.K. Mechanisms of cross hypo-responsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126 (2004) 1054-1070
47. Poltorak A., He X., Smirnova I., Liu M.Y., van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
48. Rhen M., Eriksson S., Clements M., Bergström S., and Normark S.J. The basis of persistent bacterial infections. Trends Microbiol. 11 (2003) 80-86
49. Sadeyen J.R., Trotereau J., Protais J., Beaumont C., Sellier N., Salvat G., Velge P., and Lalmanach A.C. Salmonella carrier state in hens: study of host resistance by a gene expression approach. Microbes Infect. 8 (2006) 1308-1314
50. Safdar A., White D.A., Stover D., Armstrong D., and Murray H.W. Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis. Am. J. Med. 113 (2002) 756-759
51. Sashinami H., Yamamoto T., and Nakane A. The cytokine balance in the maintenance of a persistent infection with Salmonella enterica serovar Typhimurium in mice. Cytokine 33 (2006) 212-218
52. Shahin R.D., Engberg I., Hagberg I., and Eden S.C. Neutrophil recruitment and bacterial clearance correlate with LPS responsiveness in local Gram-negative infections. J. Immunol. 138 (1987) 3475-3480
53. Späth G.F., Lye L.F., Segawa H., Sacks D.L., Turco S.J., and Beverley S.M. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science 301 (2003) 1241-1243
54. Stoycheva M., and Murdjeva M. Dynamics of serum pro-inflammatory cytokines in patients with salmonella infection. Trakia J. Sci. 3 (2005) 56-60
55. Svanborg C., Frendeus B., Godaly G., Hang L., Hedlund M., and Wachtler C. Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection. J. Infect. Dis. 183 Suppl. 1 (2001) S61-S65
56. Talluri G., Marella V.K., Shirazian D., and Wise G.J. Immune response in patients with persistent candiduria and occult candidemia. J. Urol. 162 (1999) 1361-1364
57. Trinchieri G. Interleukin 12: a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13 (1995) 251-276
58. Tripp C.S., Wolf S.F., and Unanue E.R. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90 (1993) 3725-3729
59. Ulrichs T., and Kaufmann S.H. New insights into the function of granulomas in human tuberculosis. J. Pathol. 208 (2006) 261-269
60. Verstack B., Hertzog P., and Mansell A. Toll-like receptor signaling and the clinical benefits that lie within. Inflamm. Res. 56 (2007) 1-10
61. Via L.E., Fratti R.A., McFalone M., Pagan-Ramos E., Deretic D., and Deretic V. Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci. 111 (1998) 897-905
62. Weiss D.S., Raupach B., Takeda K., Akira S., and Zychlinsky A. Toll-like receptors are temporally involved in host defense. J. Immunol. 172 (2004) 4463-4469
63. West A.P., Koblansky A.A., and Ghosh S. Recognition and signaling by toll-like receptors. Annu. Rev. Cell Dev. Biol. 22 (2006) 409-437
64. Yamamura M., Uyemura K., Deans R.J., Weinberg K., Rea T.H., Bloom B.R., and Modlin R.L. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254 (1991) 277-279
65. Yoshimura A., Naka T., and Kubo M. SOCS proteins, cytokine signaling and immune regulation. Nature 7 (2007) 454-464
66. Young D., Hussel T., and Dougan G. Chronic bacterial infections: living with unwanted guests. Nat. Immunol. 3 (2002) 1026-1032
67. Zhang M., Lin Y., Iyer D.V., Gong J., Abrams J.S., and Barnes P.F. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63 (1995) 3231-3234